immune system
N |
• bone marrow derived dendritic cells (BMDCs) cultured under hypoxic conditions (1% oxygen) show upregulation of maturation markers such as MHCII, CD86, with CD80 only slightly enhanced; control BMDCs grown in hypoxic conditions show similar enhanced maturation markers
• cytokine production is reduced in mutant and control BMDCs under hypoxic conditions; production of Il12p70, Il10, Il6, and Il23 is decreased in mutant and control BMDCs under hypoxic conditions, with Il22 upregulated compared to normoxic cells
• stimulation by LPS does not further enhance expression of maturation markers as it does in BMDCs grown under normoxic conditions
• production of Il12p70, Il10, Il6, and Il23 is decreased in mutant and control BMDCs under hypoxic conditions, with Il22 upregulated compared to normoxic cells
|
• fewer mutant BMDCs generated under hypoxic conditions migrate toward CCL19 in a transwell chamber assay than control cells grown under hypoxic conditions or mutant and control cells generated under normoxic conditions; migration toward CXCL12 is not different from controls under hypoxic or normoxic conditions
|
• bone marrow dendritic cells (BMDCs) differentiated under hypoxic conditions in culture display reduced growth (proliferation) compared to control cells grown in hypoxia or mutant cells grown under normoxic (21% oxygen) conditions
|
• BMDCs produce similar levels of Il-1b under hypoxic and normoxic conditions while control cells and BMDCs with CD11c-driven Hif1a deletion show decreased production under hypoxic conditions
|
• BMDCs produce similar levels of TNFalpha under hypoxic and normoxic conditions while control cells and BMDCs with CD11c-driven Hif1a deletion show decreased production under hypoxic conditions
|
cellular
• reduced amounts of ATP are detected in lysates of mutant BMDCs cultured under hypoxic conditions compared to control cells under hypoxia suggesting an energy metabolism defect with Hif1a deletion
|
• fewer mutant BMDCs generated under hypoxic conditions migrate toward CCL19 in a transwell chamber assay than control cells grown under hypoxic conditions or mutant and control cells generated under normoxic conditions; migration toward CXCL12 is not different from controls under hypoxic or normoxic conditions
|
hematopoietic system
• fewer mutant BMDCs generated under hypoxic conditions migrate toward CCL19 in a transwell chamber assay than control cells grown under hypoxic conditions or mutant and control cells generated under normoxic conditions; migration toward CXCL12 is not different from controls under hypoxic or normoxic conditions
|
• bone marrow dendritic cells (BMDCs) differentiated under hypoxic conditions in culture display reduced growth (proliferation) compared to control cells grown in hypoxia or mutant cells grown under normoxic (21% oxygen) conditions
|